MolNFT v1 · #102855 · protein
Human solac complexed with 1-benzofuran-2-carboxylic acid
4OYP · Adenylate cyclase type 10: “Human solac complexed with 1-benzofuran-2-carboxylic acid”. X-ray diffraction, 3 ligands (ACE, BZ2, CL), 5 pockets (best druggability 0.77). MolNFT v1 #102855 on GenesisL1: 3D structure, binding sites and…
- PDB
- 4OYP
- Type
- protein
- Length
- 468 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Adenylate cyclase type 10
- EC
- 4.6.1.1
- UniProt
- Q96PN6
- Ligands
- ACE, BZ2, CL
- Pockets
- 5 · best druggability 0.77
Structure
x-ray diffraction · 1 distinct chain · 36% helix, 27% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Adenylate cyclase type 10 (EC 4.6.1.1) | protein | 468 | 36% helix, 27% strand | Q96PN6 |
Ligands and binding sites
- ACE · Acetyl group · ligand · chains A
- BZ2 · 1-benzofuran-2-carboxylic acid · ligand · chains A
- CL · Chloride ion · ion · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 247 | 0.77 | 0.90 | 33 | empty |
| 2 | 341 | 0.72 | 0.84 | 44 | CL, BZ2 |
| 3 | 195 | 0.65 | 0.84 | 34 | empty |
| 4 | 148 | 0.43 | 0.75 | 22 | empty |
| 5 | 82 | 0.35 | 0.75 | 18 | empty |
Modifications
Observed in the structure: 1 covalent, 1 modified (covalent ligand, artifact).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q96PN6
- Elsewhere: RCSB PDB 4OYP · PDBe 4OYP · UniProt Q96PN6
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.